Archan Khandekar, MD, presented “Leveraging Big Data in Surgery through HL7 Integration and Computer Vision” during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 8, 2024.
How to cite: Khandekar, Archan. “Leveraging Big Data in Surgery through HL7 Integration and Computer Vision.” October 8, 2024. Accessed Dec 2024. https://grandroundsinurology.com/leveraging-big-data-in-surgery-through-hl7-integration-and-computer-vision/
Leveraging Big Data in Surgery through HL7 Integration and Computer Vision – Summary
Archan Khandekar, MD, delivers a compelling presentation on integrating Big Data into surgery. The 10-minute talk explores the evolution of healthcare data, from adopting electronic health records to cutting-edge technologies like computer vision and AI-driven surgical assistance.
Dr. Khandekar highlights how traditional data sources such as labs and medical histories are now complemented by innovative tools like operative videos and robotic kinematic data. He delves into the transformative role of AI in enhancing surgical workflow, predicting outcomes, and improving documentation accuracy. He includes real-world applications, such as using computer vision to calculate ischemia times and integrating data from diverse sources to scale analytics for large populations.
Challenges, including data privacy, user adoption, and system integration, are addressed alongside ethical considerations in AI implementation. With a forward-looking perspective, Dr. Khandekar envisions a future where AI supports real-time intraoperative guidance and skill assessment.
The Global Summit on Precision Diagnosis and Treatment of Prostate Cancer is a unique multi-disciplinary forum organized to inform the key health care stakeholders about the emerging advances in clinical case and research and create a consensus-based vision for the future of precision care and educational and research strategy for its realization. The mission of the Summit is to fill the currently existing gap between the key experts of in vivo imaging, the world authorities in the in vitro fluid- and tissue-based molecular diagnostics, including genomics, and thought leaders in the development of novel observation strategies (e.g., active surveillance, or AS) and therapeutic interventions.
